Telomir Pharmaceuticals, Inc. Common Stock
TELO
$1.11-0.89%
Delayed · as of Oct 12, 2026, 11:01 AM ET
Mkt cap
$85.97M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-0.04
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Use this TELO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TELO income, balance, and cash tables.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company in the Healthcare sector.
Latest cached Telomir Pharmaceuticals, Inc. Common Stock (TELO) net income for FY2025 was -$10.4M. Statements: https://lician.com/financials/telo
Telomir Pharmaceuticals, Inc. Common Stock (TELO) market capitalization is $86.0M on the latest cached snapshot.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) cached previous close $1.12; day range $1.10 – $1.13; volume 15,634. Session quote: https://lician.com/quote/telo
Telomir Pharmaceuticals, Inc. Common Stock (TELO) latest cached earnings event is "TELO earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TELO filing is 8-K · Oct 6, 2026. Filings: https://lician.com/sec/telo